Scientific Sessions

Scientific Sessions

Dated 23.10.2020*

THE CONFERENCE WILL BE HELD ACCORDING TO ISRAEL STANDARD TIME (IST UTC +2)

12:30-12:35
Prof. Raphael Mechoulam
Institute for Drug Research, The Hebrew University of Jerusalem, Israel

12:35-12:40
Mr. Yossi Bornstein
Founder & CEO of Shizim Group; Founder & Partner of Cann10, Israel

12:40-12:45
Mr. Yuli (Yoel) Edelstein
Minister of Health, Israel

12:45-13:15
IF WE CANNOT CHANGE THE FUTURE AT LEAST WE CAN CHANGE OUR ATTITUDE
Prof. Dedi Meiri
Assistant Professor, Heads the ``Laboratory of Cancer Biology and Cannabinoid Research``, Technion, Israel Institute of Technology, Israel

13:15-13:30
Live Discussion/Q&A

14:00-14:30
MEDICAL GRADE CANNABIS: DEFINITIONS AND CONCEPTS
Dr. Raquel Peyraube
Executive Committee, the International Association for Cannabinoid Medicines, Uruguay

14:30-14:45
Live Discussion/Q&A

.

14:45-16:00
GRAND ROUNDS: REAL-LIFE STORIES FROM THE CLINICAL PRACTICE 

14:45-15:05
Dr. Orit Stolar 
Pediatric Neurologist, Assaf Harofeh Medical Center, Israel

15:25-15:45
Dr. Addie Ron 
Medical Director, NiaMedic, Israel

15:20-15:40
Dr. Bareket Schiff Keren
Pain Specialist, Tel Aviv Medical Center, Israel

15:45-16:00
Live Discussion/Q&A

14:45-15:45

LIVE SESSION – CULTIVATING SCIENCE IN THE MEDICAL CANNABIS BUSINESS

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

 

.

16:30-17:30
COVID-19, CBD AND CANNABIS

16:30-16:50
THE YIN AND YANG OF THE ENDOCANNABINOID SYSTEM IN IMMUNOCOMPETENCE: IMPLICATIONS FOR COVID-19
Dr. Michelle Sexton
Assistant Adjunct Professor, Department of Anesthesiology, Voluntary Clinical Instructor, Department of Family Medicine and Public Health, University of San Diego California, USA

16:50-17:10
CANNABINOIDS AS ADJUNCT ANTI-VIRAL THERAPY FOR INFLAMMATION ASSOCIATED WITH SARS-COV2
Prof. Siddappa N. Byrareddy
Associate Professor, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, USA

17:10-17:30
Live Discussion/Q&A

16:30-17:30

LIVE SESSION – PANEL DISCUSSION: WOMEN IN THE FOREFRONT OF CANNABIS INNOVATION

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

Industry session not included in the main event CME/CPD credit

THE CONFERENCE WILL BE HELD ACCORDING TO ISRAEL STANDARD TIME (IST UTC +2)

13:45-14:10
CANNABIS PLANT SCIENCE: INTERPLAY BETWEEN CANNABINOIDS AND ENVIRONMENTAL CONDITIONS
Dr. Nirit Bernstein
Senior Research Scientist, ARO, Volcani Institute, Israel

14:10-14:20
Live Discussion/Q&A

Industry session not included in the main event CME/CPD credit

Industry session not included in the main event CME/CPD credit

15:30 - 16:30

.

15:30-16:30
LIVE SESSION – ROUND TABLE DISCUSSION: PUBLIC HEALTH IMPLICATIONS

15:30-15:50
SELF-MEDICATION WITH CANNABIS: THE ASSOCIATION BETWEEN PHYSICAL PAIN, SLEEP AND CANNABIS USE IN DAILY LIFE OF RECREATIONAL CANNABIS USERS
Dr. Sharon Sznitman
Lecturer, School of Public Health, University of Haifa, Israel

15:50-16:10
HOW TO IMPROVE RATIONALITY IN NATIONAL AND INTERNATIONAL POLICIES ON MEDICAL CANNABIS
Prof. David Nutt
Professor, Imperial College London, UK

16:10-16:30
Live Q&A

15:30-16:30

LIVE SESSION – THE INTERPLAY OF SCIENCE, BUSINESS AND LAW

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

.

17:00-17:45
LIVE SESSION – ROUND TABLE DISCUSSION: CANNABINOIDS AND THE ELDERLY

Dr. Dustin Sulak
M.D., Founder and Medical Director, Healer.com, USA

Dr. Jeffrey Hergenrather
Founding member, Society of Cannabis Clinicians, USA

17:35-17:45
Live Q&A

17:00-17:45

WORKSHOP: CANNABIS EXTRACTION AND PURIFICATION METHODS: YOU NEED TO FOCUS IN COMPLIANCE AND THE FINAL PRODUCT REQUIRED

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

17:45 - 19:00

.

17:45-19:00
MEDICAL CANNABIS AND CANCER CARE

17:45-18:05
THE ANTI-CANCER POTENTIAL OF CANNABINOIDS
Prof. Manuel Guzman
Professor of Biochemistry and Molecular Biology at Madrid Complutense University, Spain

18:05-18:25
CBD FOR TREATMENT OF GRAPH-VERSUS-HOST DISEASE
Dr. Moshe Yeshurun
Head of Bone Marrow Transplantation Unit, Rabin Medical Center, Israel

18:25-18:45
INTEGRATING CANNABIS INTO CANCER CARE
Prof. Donald Abrams
Chief of the Hematology-Oncology Division, San Francisco General Hospital and a Professor of Clinical Medicine, the University of California San Francisco, USA

18:45-19:00
Live Discussion/Q&A

17:45-18:45

INTEGRATING SCIENCE AND BUSINESS: A BRAZILIAN PERSPECTIVE

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

THE CONFERENCE WILL BE HELD ACCORDING TO ISRAEL STANDARD TIME (IST UTC +2)

.

15:30-16:15
MEDICAL CANNABIS TREATMENTS: CLINICAL CONSIDERATIONS: PART A

15:30-15:45
THE WORLD OF CANNABIS
Dr. Uma Dhanabalan
Founder/CEO Global Health & Hygiene Solutions, LLC / Uplifting Health & Wellness, USA

15:45-16:00
TREATING CHILDREN WITH MEDICAL CANNABIS
Dr. Bonni Goldstein
Medical Director and Owner, Canna-Centers Wellness & Education, USA

16:00-16:15
Live Discussion/Q&A

15:30-16:30

LIVE SESSION – ROUND TABLE DISCUSSION: MEDICAL CANNABIS AND THE ROLE OF PHARMACISTS: THE ISRAELI EXPERIENCE

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

16:15 - 17:30

.

16:15-17:00
MEDICAL CANNABIS TREATMENTS: CLINICAL CONSIDERATIONS: PART B

16:15-16:30
SIDE-EFFECTS AND ADVERSE EFFECTS OF CANNABINOID MEDICINES
Dr. Franjo Grotenhermen
Executive Director, International Association for Cannabinoid Medicines IACM, Germany

16:30-16:45
INTERACTIONS OF CANNABINOIDS WITH OTHER TREATMENTS
Prof. Marta Vázquez
Professor, Pharmaceutical Sciences Department, Faculty of Chemistry, Universidad de la República, Montevideo, Uruguay

16:45-17:00
Live Discussion/Q&A

16:45-17:30

MEET THE EXPERTS: CLINICAL STUDIES AND MEDICAL CANNABIS

Industry session not included in the main event CME/CPD credit

Click HERE for the session content

17:30-17:50
TUNING THE ENDOCANNABINOID SYSTEM: WHEN TREATMENT MATCHES THE PATIENT
Dr. Fabricio Pamplona
Head of Science – CSO, Proprium Health Technology and Science, Brazil

17:50-18:10
SELECTION AND DOMESTICATION OF CANNABIS STRAINS AS A BASIS FOR MEDICINE DEVELOPMENTS
Prof. Hinanit Koltai
Senior Research Scientist, Agricultural Research Organization, Volcani Center, Israel

18:10-18:30
TOPICAL CANNABIS-BASED MEDICINES (TCBM): A NOVEL PARADIGM FOR INTEGUMENTARY & WOUND MANAGEMENT
Dr. Vincent Maida
Associate Professor, University of Toronto, Canada

18:30-18:45
Live Discussion/ Q&A

Mr. Yossi Bornstein
Founder & CEO of Shizim Group; Founder & Partner of Cann10, Israel

Prof. Raphael Mechoulam
Institute for Drug Research, The Hebrew University of Jerusalem, Israel

Prof. Raphael Mechoulam
Institute for Drug Research, The Hebrew University of Jerusalem, Israel

* could be subject to change